Abstract
Get full access to this article
View all access options for this article.
References
1.
Farr
B
. Rifamycins . In:
Mandell
GL
Bennett
JE
Dolin
R
, eds. Principles and practice of infectious diseases . Vol 1 . 5th ed. New York : Churchill Livingstone , 2000 : 348 –60 .
2.
Fahal
IH
Williams
PS
Clark
RE
Bell
GM
. Thrombotic thrombocytopenic purpura due to rifampicin . BMJ 1992 ; 304 : 882 .
3.
Dlott
JS
Danielson
CF
Blue-Hnidy
DE
McCarthy
LJ
. Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review . Ther Apher Dial 2004 ; 8 : 102 –11 .
4.
Tsai
HM
. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura . J Am Soc Nephrol 2003 ; 14 : 1072 –81 .
5.
Naranjo
CA
Busto
U
Sellers
EM
Sandor
P
Ruiz
I
Roberts
EA
, et al. A method for estimating the probability of adverse drug reactions . Clin Pharmacol Ther 1981 ; 30 : 239 –45 .